Deanine Halliman

Director, Clinical Development Avidity Biosciences, Inc.

Seminars

Thursday 7th May 2026
Panel Discussion: Amplifying Patient Advocacy Impact to Drive Measurable Outcomes
10:00 am
  • Best methods for partnering with ultra rare and larger rare patient organizations that maximize measurable outcomes and build-in evaluation components
  • Collaboration on data collection from external patient advocacy initiatives without breaching compliance
  • Supporting patient engagement efforts that maximize community impact while demonstrating value to your organization
  • Understanding the value of building meaningful relationships with Patient Advocacy Organization that lead to successful outcomes for patients and your organization
Deanine Halliman, Director of Clinical Development at Avidity Biosciences, speaking at 3rd Measuring Patient Engagement Conference